Introduction
============

Relatively little is known about the end of life (EOL) trajectories of adolescents and young adults (AYA; aged 15--24 years) with life-limiting illnesses. In this context, EOL trajectories represent utilization patterns prior to the EOL in regards to costs, provider visits, hospitalizations, interventions, and general access to the health care system.[@b1-ahmt-9-117] Of the reports that exist, most focus on AYA with cancer.[@b1-ahmt-9-117]--[@b5-ahmt-9-117] Roughly three-fourths of young people who die do so in an intensive care setting with numerous burdensome symptoms and distress at the EOL.[@b6-ahmt-9-117] There is a dearth of information on the influence of hospice care on AYA's EOL quality care outcomes. What is known suggests that hospice care allows for a comprehensive and family-centered approach at the EOL that incorporates symptom management, psychosocial and spiritual support, life review, and goal setting for those with a life expectancy of ≤6 months.[@b6-ahmt-9-117]--[@b8-ahmt-9-117] Hospice care is reimbursed by both Medicare and Medicaid, and individuals who are not covered by either of these entities must acquire private insurance to receive hospice care benefits.[@b9-ahmt-9-117]

AYAs with life-limiting illness are at risk of receiving fragmented care due to having both pediatric and adult health care providers, along with multiple transitions between environments of care. Even within the adolescent and young adult age group, preliminary evidence suggests that young adults (aged 20--24 years) are at great risk due to care transitions both in providers and insurance coverage, but most of this literature has been limited to those with cancer diagnoses.[@b5-ahmt-9-117],[@b10-ahmt-9-117],[@b11-ahmt-9-117] To our knowledge, examination of hospice care use has not yet been explored for young people who are covered through private insurance. Thus, the purpose of this study was to generate baseline data on the health characteristics, health care utilization, and health care spending among privately insured AYA, who enrolled in hospice care during their last year of life. A secondary purpose of this study was to explore differences in hospice length of stay (LOS) between adolescents (aged 15--19 years) and young adults (aged 20--24 years).

Methods
=======

Data source
-----------

We analyzed de-identified claims data contained within the Truven Health Marketscan™ Commercial Claims and Encounters database.[@b12-ahmt-9-117] This national database provides individual-level data from active employees, early retirees, Consolidated Omnibus Budget Reconciliation Act continues, and dependents, who are insured from employer-sponsored plans.[@b12-ahmt-9-117] These data link paid claims and encounter data to detailed patient information across sites and types of providers and over time. Quality standards for the MarketScan Research Databases are maintained by Truven.[@b8-ahmt-9-117] The study was approved by the Penn State College of Medicine Institutional Review Board prior to study start.

Cohort selection
----------------

### Variables of interest

Variables used in this analysis included 1) demographic characteristics (year enrolled, age, sex, region, and metropolitan \[rural vs urban\] assessment); 2) health characteristics of AYA (assessment of complex chronic conditions \[CCCs\] based on ICD-9 codes developed by Feudtner et al[@b13-ahmt-9-117]); 3) health insurance plan characteristics (plan type and relation to employee); 4) utilization (hospice LOS, primary care use, hospital use \[three or more hospital admissions\], emergency department use, procedure use); and 5) spending (monthly net insurance payment, monthly total payment, monthly copayment, monthly deductible, monthly coinsurance, monthly coordination of benefits) adjusted to 2014 dollars. Monthly net insurance payment is calculated by total payment minus deductible minus copayment minus coinsurance minus coordination of benefits.

### Analysis

Descriptive statistics including frequencies, mean, standard deviations, and ranges were calculated on all variables in the sample. Analysis of variance was used to compare mean hospice LOS (15--19 vs 20--24 years). Values for spending variables were winsorized at the 1st and 99th percentiles to minimize the influence of outliers.

Results
=======

Our sample comprised 17,408 AYA who used hospice care services during the last year of life. Demographic characteristics of the sample can be found in [Table 1](#t1-ahmt-9-117){ref-type="table"}. The majority of the sample was derived from years 2010--2014, aged 20--24, female, and resided in urban settings in the South. Approximately 20% of the sample had a CCC documented within the year prior to death, of which malignancy was the most common (n=1,708). Additionally, the majority of the sample had a preferred provider organization for plan type (63.2%) followed by a point of service (POS) plan (26.9%). In terms of the relation to the employee with the private insurance, 59.2% of the AYA in this sample were listed as "child", 35.8% were themselves the employee, and 4.7% were classified as "spouse".

Spending and utilization data are displayed in [Table 2](#t2-ahmt-9-117){ref-type="table"}. More than a third (37%) of the AYAs used the emergency department during the last year of life and 83% sought care from a primary care visit. However, only 6% of the sample used frequent inpatient hospital services (more than three times) during this EOL trajectory. There was a statistically significant difference in hospice LOS among those aged 15--19 years (mean 3.56, SD 15.17 days) compared with those aged 20--24 years (mean 2.26, SD 8.24 days; *P*\<0.001). The AYA in this sample had average net insurance payments that exceeded \$2,000 per month.

Discussion
==========

This study provides preliminary data on health care utilization and spending for AYA who were enrolled in hospice. AYA in this sample had relatively high primary care utilization and very few had recurrent hospitalizations. The average hospice LOS was low, with adolescents having longer LOS in hospice than young adults. This finding was consistent with other reports of children and adolescents.[@b2-ahmt-9-117],[@b14-ahmt-9-117] From a developmental perspective, AYAs at the EOL are at particular risk of anticipatory grief and unmet psychosocial needs,[@b15-ahmt-9-117],[@b16-ahmt-9-117] and hospice represents a model of comprehensive care that allows for both psychological care and enhanced symptom management.[@b17-ahmt-9-117] While AYA have been a recognized population at risk of health disparities in cancer,[@b18-ahmt-9-117]--[@b20-ahmt-9-117] there is a need to explore the disparities in health care among this age group beyond just those with cancer.[@b10-ahmt-9-117],[@b11-ahmt-9-117],[@b21-ahmt-9-117]

The majority of AYA in our study did not have a CCC documented in the year prior to their death, which suggests that their health problems might be traumatic/acute in nature. This finding could also represent a lack of ongoing International Classification of Disease (ICD-9) codification of underlying chronic conditions, which represents a limitation in using private health insurance claims data for analyses at the EOL, where the presenting problems are likely more episodic and acute in nature. Given this finding, there are numerous implications for how to involve hospice care earlier in the acute illness trajectory. Additionally, there are implications for continued coverage of those with preexisting health conditions given that over a third of this sample maintained coverage for themselves because they were the primary beneficiary of the health plan. This study also highlights the implications for seriously ill youth to be able to obtain coverage on their parents' private health insurance plan up to age of 26 years per the Affordable Care Act.[@b1-ahmt-9-117]

There are several limitations to note. This database did not have any death codes, so we used end of service claims as a proxy for death. Additionally, those who received hospice benefits through dual coverage in Medicaid would not be captured in this analysis. More longitudinal studies are needed to determine the impact of hospice on clinical outcomes among AYA.

Conclusion
==========

Examination of hospice care use among privately insured AYAs has not yet been explored. This analysis provides baseline data on the health characteristics, health care utilization, and health care spending among privately insured AYA, who were enrolled in hospice care during their last year of life.
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###### 

Patient demographics and health characteristics (n=17,408)

  Variable                             Frequency   Percent
  ------------------------------------ ----------- ---------
  **Years enrolled**                               
  2005--2009                           3,380       19.4
  2010--2014                           14,028      80.6
  **Age (years)**                                  
  15--19                               5,761       33.1
  20--24                               11,647      66.9
  **Sex**                                          
  Male                                 5,323       30.6
  Female                               12,085      69.4
  **Region**                                       
  Northeast                            3,117       17.9
  North central                        2,635       15.1
  South                                8,984       51.6
  West                                 2,672       15.4
  **Relation to insurance enrollee**               
  Self                                 6,226       35.8
  Spouse                               821         4.7
  Child                                10,361      59.2
  **Insurance plan type**                          
  Preferred provider organization      10,573      63.2
  Point of service                     4,508       26.9
  Other                                2,327       9.9
  **Metropolitan**                                 
  Rural                                1,473       8.5
  Urban                                15,935      91.5
  **CCC category**                                 
  Neuromuscular                        757         15.61
  Cardiovascular                       687         14.17
  Respiratory                          65          1.34
  Renal                                105         2.17
  Gastrointestinal                     290         5.98
  Hematology/Immunodeficiency          182         3.75
  Metabolic                            678         13.99
  Congenital(other)                    376         7.76
  Malignancy                           1,708       35.23
  Total (not mutually exclusive)       4,848       
  **Number of CCCs**                               
  0                                    13,930      80.02
  1                                    2,527       14.52
  2                                    651         3.74
  3                                    213         1.22
  4                                    64          0.37
  5                                    15          0.09
  6                                    7           0.04
  7                                    1           0.01

**Abbreviation:** CCCs, complex chronic conditions.

###### 

Spending and utilization of hospice enrollees

  Utilization                                               Frequency/Mean   Percent/SD
  --------------------------------------------------------- ---------------- ------------
  **Hospice** LOS (days)                                                     
  Ages 15--19 years                                         3.56             15.17
  Ages 20--24 years                                         2.26             8.24
  **Emergency department use**                                               
  No                                                        11,000           63.20
  Yes                                                       6,408            36.80
  **Primary care use**                                                       
  No                                                        2,958            16.99
  Yes                                                       14,450           83.01
  **Hospital use (more than three admissions past year)**                    
  No                                                        16,370           94.04
  Yes                                                       1,038            5.96
  **Procedure classifications**                                              
  Office visit, established                                 12,104           6.82
  Office visit, new                                         8,475            4.77
  Microbiology tests                                        7,962            4.48
  Lab tests                                                 7,482            4.21
  Preventive care                                           7,459            4.2
  Venipuncture                                              7,310            4.12
  Other chemistry tests                                     6,745            3.8
  Routine urinalysis                                        5,965            3.36
  Pap smear                                                 5,862            3.3
  Blood count                                               5,285            2.98
  **Spending**                                              **Mean**         **SD**
  Monthly total payment (USD)                               2,269.51         7,956.21
  Monthly net insurance payment                             2,113.48         7,786.51
  Monthly copay                                             14.83            27.76
  Monthly deductible                                        46.95            79.08
  Monthly coinsurance                                       54.52            130.83
  Monthly coordination of benefits                          4.64             33.11

**Abbreviation:** LOS, length of stay.
